Insulin aspart and insulin degludec Subcutaneous and Mogamulizumab-kpkc Intravenous
Determining the interaction of Insulin aspart and insulin degludec Subcutaneous and Mogamulizumab-kpkc Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart / insulin degludec
Brand name: Ryzodeg 70/30 FlexTouch
Synonyms: Insulin aspart and insulin degludec (Subcutaneous)
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart and insulin degludec Subcutaneous-Molindone
- Insulin aspart and insulin degludec Subcutaneous-Mometasone (Oral Inhalation)
- Insulin aspart and insulin degludec Subcutaneous-Mometasone and Formoterol
- Insulin aspart and insulin degludec Subcutaneous-Mometasone and formoterol Inhalation
- Insulin aspart and insulin degludec Subcutaneous-Mometasone Cream
- Insulin aspart and insulin degludec Subcutaneous-Mometasone Furoate
- Mogamulizumab-kpkc Intravenous-Insulin Aspart Injection
- Mogamulizumab-kpkc Intravenous-Insulin Aspart Protamine and Insulin Aspart
- Mogamulizumab-kpkc Intravenous-Insulin aspart protamine and insulin aspart Subcutaneous
- Mogamulizumab-kpkc Intravenous-Insulin Aspart Protamine and Insulin Aspart (Cartridges and Prefilled Pens)
- Mogamulizumab-kpkc Intravenous-Insulin Aspart Protamine and Insulin Aspart (Vials)
- Mogamulizumab-kpkc Intravenous-Insulin Aspart Protamine Injection